Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Report 2024 Including Stages Of Development, Segments, Region And Countries, Regulatory Path And Key Companies

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Magnetic Resonance Imaging (MRI) Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's offering.
The Medical Devices sector report provides comprehensive information about the Magnetic Resonance Imaging (MRI) Contrast Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Report Scope

• Extensive coverage of the Magnetic Resonance Imaging (MRI) Contrast Agents under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Magnetic Resonance Imaging (MRI) Contrast Agents and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Magnetic Resonance Imaging (MRI) Contrast Agents under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:
Introduction

• Magnetic Resonance Imaging (MRI) Contrast Agents Overview

Products under Development

• Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Stage of Development
• Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Segment
• Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Territory
• Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Regulatory Path
• Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Estimated Approval Date
• Magnetic Resonance Imaging (MRI) Contrast Agents - Ongoing Clinical Trials

Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products under Development by Companies

• Magnetic Resonance Imaging (MRI) Contrast Agents Companies - Pipeline Products by Stage of Development
• Magnetic Resonance Imaging (MRI) Contrast Agents - Pipeline Products by Stage of Development

Magnetic Resonance Imaging (MRI) Contrast Agents Companies and Product Overview
Magnetic Resonance Imaging (MRI) Contrast Agents- Recent Developments
Company Coverage:

• 5M Biomed
• Adamas Nanotechnologies Inc
• Alzeca Biosciences Inc
• Antaros Medical AB
• Ascelia Pharma AB
• B-Aegis Life Sciences & Research Pvt Ltd
• Bayer AG
• BBS NanoTechnology Ltd
• Brown University
• Case Western Reserve University
• EOS Biosciences Inc (Inactive)
• Ferric Contrast Inc
• GE HealthCare Technologies Inc
• Georgia State University
• Hana Pharm Co Ltd
• Harvard University
• Hugo W. Moser Research Institute at Kennedy Krieger Inc
• IC Targets AS
• Imagion Biosystems Inc
• iMax Diagnostic Imaging Ltd
• Indian Institute of Technology Delhi
• Inlighta Biosciences LLC
• Inventera Pharmaceutical Co Ltd
• Iowa State University
• King's College London
• Knowledgepie Pvt Ltd
• LadeRx LLC
• Lantheus Medical Imaging Inc
• Lipella Pharmaceuticals Inc
• Massachusetts General Hospital
• Massachusetts Institute of Technology
• Molecular Theranostics LLC
• Nanosion Co Ltd
• National University of Singapore
• Northwestern University
• Polarean Imaging PLC
• QurCan Therapeutics Inc
• Reveal Pharmaceutical Inc
• SG Endocrine Research LLC
• Signablok Inc
• Southern Illinois University Carbondale
• SPAGO Nanomedical AB
• Sree Chitra Tirunal Institute for Medical Sciences & Technology
• SunTech Medical Inc
• The Chinese University of Hong Kong
• Theragnostic Technologies Inc
• Videns og Forskningscenter for Alternativ Behandling
• Voyageur Pharmaceuticals Ltd
• Washington University in St Louis
• Wayne State University
• Weizmann Institute of Science
• Xemed

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

MENAFN27112024004107003653ID1108931007